BACKGROUND: Pulse oximeter performance is degraded by motion artifacts and low perfusion. Manufacturers developed algorithms to improve instrument performance during these challenges. There have been no independent comparisons of these devices. METHODS: We evaluated the performance of four pulse oximeters (Masimo Radical-7, USA; Nihon Kohden OxyPal Neo, Japan; Nellcor N-600, USA; and Philips Intellivue MP5, USA) in 10 healthy adult volunteers. Three motions were evaluated: tapping, pseudorandom, and volunteer-generated rubbing, adjusted to produce photoplethsmogram disturbance similar to arterial pulsation amplitude. During motion, inspired gases were adjusted to achieve stable target plateaus of arterial oxygen saturation (SaO2) at 75%, 88%, and 100%. Pulse oximeter readings were compared with simultaneous arterial blood samples to calculate bias (oxygen saturation measured by pulse oximetry [SpO2] - SaO2), mean, SD, 95% limits of agreement, and root mean square error. Receiver operating characteristic curves were determined to detect mild (SaO2 < 90%) and severe (SaO2 < 80%) hypoxemia. RESULTS: Pulse oximeter readings corresponding to 190 blood samples were analyzed. All oximeters detected hypoxia but motion and low perfusion degraded performance. Three of four oximeters (Masimo, Nellcor, and Philips) had root mean square error greater than 3% for SaO2 70 to 100% during any motion, compared to a root mean square error of 1.8% for the stationary control. A low perfusion index increased error. CONCLUSIONS: All oximeters detected hypoxemia during motion and low-perfusion conditions, but motion impaired performance at all ranges, with less accuracy at lower SaO2. Lower perfusion degraded performance in all but the Nihon Kohden instrument. We conclude that different types of pulse oximeters can be similarly effective in preserving sensitivity to clinically relevant hypoxia.
BACKGROUND: Pulse oximeter performance is degraded by motion artifacts and low perfusion. Manufacturers developed algorithms to improve instrument performance during these challenges. There have been no independent comparisons of these devices. METHODS: We evaluated the performance of four pulse oximeters (Masimo Radical-7, USA; Nihon Kohden OxyPal Neo, Japan; Nellcor N-600, USA; and Philips Intellivue MP5, USA) in 10 healthy adult volunteers. Three motions were evaluated: tapping, pseudorandom, and volunteer-generated rubbing, adjusted to produce photoplethsmogram disturbance similar to arterial pulsation amplitude. During motion, inspired gases were adjusted to achieve stable target plateaus of arterial oxygen saturation (SaO2) at 75%, 88%, and 100%. Pulse oximeter readings were compared with simultaneous arterial blood samples to calculate bias (oxygen saturation measured by pulse oximetry [SpO2] - SaO2), mean, SD, 95% limits of agreement, and root mean square error. Receiver operating characteristic curves were determined to detect mild (SaO2 < 90%) and severe (SaO2 < 80%) hypoxemia. RESULTS: Pulse oximeter readings corresponding to 190 blood samples were analyzed. All oximeters detected hypoxia but motion and low perfusion degraded performance. Three of four oximeters (Masimo, Nellcor, and Philips) had root mean square error greater than 3% for SaO2 70 to 100% during any motion, compared to a root mean square error of 1.8% for the stationary control. A low perfusion index increased error. CONCLUSIONS: All oximeters detected hypoxemia during motion and low-perfusion conditions, but motion impaired performance at all ranges, with less accuracy at lower SaO2. Lower perfusion degraded performance in all but the Nihon Kohden instrument. We conclude that different types of pulse oximeters can be similarly effective in preserving sensitivity to clinically relevant hypoxia.
Authors: Eric D McCollum; Carina King; Tim Colbourn; Hamish Graham; Mike Bernstein; Iain H Wilson; William Checkley Journal: Lancet Respir Med Date: 2019-10-17 Impact factor: 30.700
Authors: Valeria S M Valbuena; Sarah Seelye; Michael W Sjoding; Thomas S Valley; Robert P Dickson; Steven E Gay; Dru Claar; Hallie C Prescott; Theodore J Iwashyna Journal: BMJ Date: 2022-07-06
Authors: Valeria S M Valbuena; Ryan P Barbaro; Dru Claar; Thomas S Valley; Robert P Dickson; Steven E Gay; Michael W Sjoding; Theodore J Iwashyna Journal: Chest Date: 2021-09-27 Impact factor: 10.262
Authors: Carlos Areia; Sarah Vollam; Louise Young; Christopher Biggs; Marco Pimentel; Mauro Santos; Neal Thurley; Stephen Gerry; Lionel Tarassenko; Peter Watkinson Journal: BMJ Open Date: 2021-05-18 Impact factor: 2.692
Authors: Jeremy C Cornelissen; Bruce E Blough; Laura M Bohn; S Stevens Negus; Matthew L Banks Journal: Behav Pharmacol Date: 2021-08-01 Impact factor: 2.277
Authors: Michael W Sjoding; Robert P Dickson; Theodore J Iwashyna; Steven E Gay; Thomas S Valley Journal: N Engl J Med Date: 2020-12-17 Impact factor: 176.079
Authors: Carlos Areia; Sarah Vollam; Philippa Piper; Elizabeth King; Jody Ede; Louise Young; Mauro Santos; Marco A F Pimentel; Cristian Roman; Mirae Harford; Akshay Shah; Owen Gustafson; Matthew Rowland; Lionel Tarassenko; Peter J Watkinson Journal: BMJ Open Date: 2020-01-12 Impact factor: 2.692